This narrative review in the British Journal of Biomedical Science examines emerging and recently approved therapeutic strategies to combat antimicrobial resistance, spanning new antibiotics, microbiome interventions, natural products, predatory bacteria, vaccines, and advanced technologies. It highlights both promising innovations and the urgent need for sustained global investment as many approaches remain in early development.
To continue reading click here
